Annelie H. Musters

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.

Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.

Journal: Trials

Published: February 18, 2025

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 11, 2024

Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.

Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.

Journal: The Journal of dermatology

Published: October 24, 2024

International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.

International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 26, 2024

Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.

Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.

Journal: The British journal of dermatology

Published: March 25, 2024

The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.

The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.

Journal: Trials

Published: March 11, 2024

Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.

Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.

Journal: The Journal of allergy and clinical immunology

Published: December 23, 2023

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.

Journal: Allergy

Published: November 27, 2023

Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.

Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 12, 2023

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.

Journal: The Journal of investigative dermatology

Published: January 21, 2023

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.

Journal: BMC infectious diseases

Published: November 15, 2022

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.

Journal: Journal of autoimmunity

Published: October 24, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026